KR101158603B1 - 비강용 스프레이를 전달하는 방법 - Google Patents

비강용 스프레이를 전달하는 방법 Download PDF

Info

Publication number
KR101158603B1
KR101158603B1 KR1020077014446A KR20077014446A KR101158603B1 KR 101158603 B1 KR101158603 B1 KR 101158603B1 KR 1020077014446 A KR1020077014446 A KR 1020077014446A KR 20077014446 A KR20077014446 A KR 20077014446A KR 101158603 B1 KR101158603 B1 KR 101158603B1
Authority
KR
South Korea
Prior art keywords
spray
olopatadine
formulation
nasal
delete delete
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020077014446A
Other languages
English (en)
Korean (ko)
Other versions
KR20070086638A (ko
Inventor
게랄드 카글
지. 마이클 왈
Original Assignee
알콘, 인코퍼레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알콘, 인코퍼레이티드 filed Critical 알콘, 인코퍼레이티드
Publication of KR20070086638A publication Critical patent/KR20070086638A/ko
Application granted granted Critical
Publication of KR101158603B1 publication Critical patent/KR101158603B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A61M11/007—Syringe-type or piston-type sprayers or atomisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020077014446A 2004-11-24 2005-10-31 비강용 스프레이를 전달하는 방법 Expired - Lifetime KR101158603B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63088604P 2004-11-24 2004-11-24
US60/630,886 2004-11-24
PCT/US2005/039268 WO2006057769A2 (en) 2004-11-24 2005-10-31 Method of delivering nasal spray

Publications (2)

Publication Number Publication Date
KR20070086638A KR20070086638A (ko) 2007-08-27
KR101158603B1 true KR101158603B1 (ko) 2012-07-09

Family

ID=36498400

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077014446A Expired - Lifetime KR101158603B1 (ko) 2004-11-24 2005-10-31 비강용 스프레이를 전달하는 방법

Country Status (19)

Country Link
US (3) US20060110328A1 (enExample)
EP (1) EP1814538B1 (enExample)
JP (1) JP5068172B2 (enExample)
KR (1) KR101158603B1 (enExample)
CN (2) CN103860540A (enExample)
AT (1) ATE443516T1 (enExample)
AU (1) AU2005309951B2 (enExample)
BR (1) BRPI0518283A2 (enExample)
CA (1) CA2586553C (enExample)
CY (1) CY1110528T1 (enExample)
DE (1) DE602005016833D1 (enExample)
DK (1) DK1814538T3 (enExample)
ES (1) ES2331619T3 (enExample)
MX (1) MX2007005845A (enExample)
PL (1) PL1814538T3 (enExample)
PT (1) PT1814538E (enExample)
SI (1) SI1814538T1 (enExample)
WO (1) WO2006057769A2 (enExample)
ZA (1) ZA200704139B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6788460B2 (en) 1998-04-15 2004-09-07 Duke University Projection screen apparatus
US6829087B2 (en) 1998-04-15 2004-12-07 Bright View Technologies, Inc. Micro-lens array based light transmitting screen with tunable gain
US6816306B2 (en) 1998-04-15 2004-11-09 Bright View Technologies Inc. Micro-lens array based light transmitting screen with high resolution and low imaging artifacts
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
HUE026162T2 (en) 2007-02-07 2016-05-30 Novartis Ag Olopatadine preparation for topical nasal administration
PT2453872E (pt) * 2009-07-17 2013-10-30 Alcon Res Ltd Regime de pulverização nasal de olopatadina para crianças
WO2011027322A1 (en) 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
GB2485604A (en) * 2010-11-22 2012-05-23 Martin Chard Device for marking a surface
US9937189B2 (en) * 2013-09-13 2018-04-10 Glenmark Specialty S.A. Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US9370483B2 (en) 2013-09-13 2016-06-21 Glenmark Specialty S.A. Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
ES2891729T3 (es) 2013-09-13 2022-01-31 Glenmark Specialty Sa Composición farmacéutica estable de dosis fija que comprende mometasona y olopatadina para la administración nasal
US10548907B2 (en) 2013-10-04 2020-02-04 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10016443B2 (en) 2013-10-04 2018-07-10 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
RU2686670C2 (ru) 2013-10-04 2019-04-30 Гленмарк Спешиалити С.А. Лечение аллергического ринита с использованием комбинации мометазона и олопатадина
US10758550B2 (en) 2013-10-04 2020-09-01 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10653661B2 (en) 2013-10-04 2020-05-19 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
CN104063850B (zh) * 2014-06-24 2017-02-01 广东互维科技有限公司 红眼修复方法
US11679210B2 (en) 2014-10-03 2023-06-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
CN107569454B (zh) * 2017-09-29 2018-05-04 深圳大佛药业股份有限公司 一种盐酸奥洛他定鼻喷雾剂及其制备方法
US12303635B2 (en) 2018-04-16 2025-05-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
US11890409B1 (en) * 2019-11-19 2024-02-06 Saeed Rezakhany Methods of curing early stages of, and preventing, upper respiratory infections and applicators therefor
USD969992S1 (en) * 2020-12-23 2022-11-15 Aptar France Sas Device for nasal spray
CN119677523A (zh) * 2022-03-02 2025-03-21 V·杜加尔 一种用于保护和治疗粘膜的过氧化氢治疗喷雾剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (enExample) * 1956-03-21 1900-01-01
US4923892A (en) * 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
DE3882614T2 (de) * 1987-08-13 1993-11-18 Glaxo Group Ltd Indol-Derivate.
JPH0323237U (enExample) * 1989-07-19 1991-03-11
US5641805A (en) * 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
FR2803612B1 (fr) * 2000-01-12 2002-12-06 Michel Jean Louis Mar Doustaly Point d'eau sanitaire adaptable a une cuvette de wc
GB0014892D0 (en) * 2000-06-16 2000-08-09 Glaxo Group Ltd Novel pharmaceutical formulation
IT1317998B1 (it) * 2000-06-26 2003-07-21 Medical Internat Licensing N V Valvola erogatrice per spray nasale.
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US20040235955A1 (en) * 2001-09-14 2004-11-25 Masami Narita Remedies for pruritus
CN1297275C (zh) * 2002-11-12 2007-01-31 爱尔康公司 抗过敏剂和类固醇用于治疗过敏性鼻炎的用途
US7812120B2 (en) * 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol

Also Published As

Publication number Publication date
WO2006057769A2 (en) 2006-06-01
DE602005016833D1 (de) 2009-11-05
ES2331619T3 (es) 2010-01-11
AU2005309951A1 (en) 2006-06-01
CY1110528T1 (el) 2015-04-29
WO2006057769A3 (en) 2006-08-31
US20060110328A1 (en) 2006-05-25
EP1814538A2 (en) 2007-08-08
PT1814538E (pt) 2009-11-10
JP2008521488A (ja) 2008-06-26
SI1814538T1 (sl) 2010-01-29
JP5068172B2 (ja) 2012-11-07
CA2586553C (en) 2015-02-10
EP1814538B1 (en) 2009-09-23
CA2586553A1 (en) 2006-06-01
EP1814538A4 (en) 2007-11-07
DK1814538T3 (da) 2009-11-02
KR20070086638A (ko) 2007-08-27
CN101065122A (zh) 2007-10-31
PL1814538T3 (pl) 2010-02-26
CN103860540A (zh) 2014-06-18
US20170172974A1 (en) 2017-06-22
BRPI0518283A2 (pt) 2008-11-11
MX2007005845A (es) 2007-07-04
AU2005309951B2 (en) 2011-07-07
US20140227326A1 (en) 2014-08-14
ATE443516T1 (de) 2009-10-15
ZA200704139B (en) 2008-10-29

Similar Documents

Publication Publication Date Title
KR101158603B1 (ko) 비강용 스프레이를 전달하는 방법
JP3712438B2 (ja) 眼科用液体調合物を目に投与するためのスプレ装置
FI85558B (fi) Foerfarande och anordning foer framstaellning av en oftalmisk spray.
CA2648553C (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
AU8102298A (en) A method for administration of active substances to the olfactory region
EP1370238B1 (en) Liquid formulations for electrohydrodynamic spraying containing polymer and suspended particles
EP1487409B1 (en) Highly aqueous liquid carrier formulations
CA3193390A1 (en) Nebulizer and nebulized anti-virals
CN108883079A (zh) 喷雾剂、喷雾装置以及喷雾组件
AU2021397963A9 (en) A composition comprising fexofenadine
WO2022123511A1 (en) A composition comprising fexofenadine
KR20030096285A (ko) 중합체 및 현탁된 입자를 함유하는 전기유체역학적 분무용액체 제제

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20070625

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20100430

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20111013

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20120518

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20120614

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20120614

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20150519

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20150519

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20160517

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20160517

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20170601

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20170601

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20180529

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20180529

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20190530

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20190530

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20200528

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20210527

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20230530

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20250529

Start annual number: 14

End annual number: 14